Date: 19.11.2019
Summary:
A French pre-clinical stage start-up develops novel solutions to treat neurodegeneration, a process linked with microtubule disorders. It develops compounds to restore microtubule stability. One application is stopping neurodegeneration of the optic nerve in glaucoma, the leading cause of irreversible blindness. The company seeks partners specialized in biopolymers and/or surface chemistry to develop drug formulation and delivery solutions into the eye under research or technical agreements.
Reference: TRFR20190621001
Country: France
Submitted: 19. 11. 2019
Keywords
Technology: Pharmaceutics; Neurology, Brain Research; Pharmaceutical Products / Drugs; Biochemistry / Biophysics; Biopolymers
Market: Biochemistry / Biophysics; Drug delivery and other equipment; Ophthalmology, ear, nose and throat diseases; Pharmaceuticals/fine chemicals
NACE: Research and experimental development on biotechnology
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Environmental biotechnology - Information about Environmental biotechnology
Science Daily - Science Magazine
Microbes stomp daffodils in creating valuable anti-Alzheimer\'s drug
New possibilities for the medical use of botulinun toxin A1